Novo Nordisk A/S scrapped a partnership with Hims & Hers Health Inc., saying the US company is using “deceptive marketing” to ...

ProPublica spent 14 months investigating the FDA’s oversight of foreign drugmakers that send medications to the U.S. These ...

New immunotherapy drugs offer some hope in the fight against Alzheimer's disease but they're too pricey for the NHS ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

A GLP-1 medication used to treat type 2 diabetes and obesity may help cut a person's monthly migraine days by about half, a ...

Novo Nordisk is ending a deal with telehealth company Hims & Hers, saying Monday that Hims has been engaging in “illegal mass ...

GLP-1 therapies primarily use single-use injectable pens, contributing to medical waste challenges. The pharmaceutical ...

Plus, we take an in-depth look at another possible weight loss solution for patients who’ve tried other methods and failed.

By Bhanvi Satija (Reuters) -Treatments designed to help patients preserve muscle while losing weight with popular obesity ...

Discover the future of Bartell Drugs as it transitions to a new identity while maintaining its community spirit.

Drugmakers are racing to develop the next wave of obesity and diabetes medications that they hope will be even more powerful ...

Cholesterol-lowering medicines are some of the most commonly prescribed, effective drugs. Influencers on TikTok have other ...